OHSU in the news

The role OHSU created to manage patient transfers

Becker's Clinical Leadership October 19, 2023
Becker’s Clinical Leadership summarizes a NEJM Catalyst case study that describes how OHSU created a new intake hospitalist role to oversee patient transfers in order to “accept ‘the right patient, at the right time, to the right place.’”

Xanax’s Efficacy Questioned

Neuroscience News October 19, 2023
Research by Erick Turner, M.D., and Rosa Ahn-Horst, M.D., M.P.H., suggests that the sedative alprazolam, also known as Xanax XR, may be less effective than believed. Turner says: “Our study throws some cold water on the efficacy of this drug."

Cancer miscommunication: A ‘common currency’ in patient encounters

HemOncToday October 17, 2023
Don Sullivan, M.D., participates in a Q&A with HemOnc Today on recently published research discussing miscommunication in cancer care. Sullivan says: “Counter to what clinicians may believe, patients expect and appreciate prognosis communication being delivered in a direct but empathetic way.”

Late-breaking clinical trials at TCT 2023

Cardiovascular Business October 17, 2023
While presenting at TCT 2023, Firas Zahr, M.D., shared “high rates of device and procedural success” in the Medtronic-sponsored early feasibility study of the Intrepid transcatheter mitral valve replacement system.

DEA extends telehealth rules to increase access to addiction treatment medicine

KATU-TV October 17, 2023
Laurel Hallock-Koppelman, D.N.P., says this of the Drug Enforcement Administration’s decision to extend coverage of telehealth substance use disorder treatment: “I’m really glad they decided to extend this. They really listened to the providers. The people with their boots on the ground that are seeing patients and seeing the benefits of telehealth."
See more stories